Qun Luo

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

Medicine, Endocrinology, Nephrology +10

Recent progress in organic solar cells (Part I material science)

Yahui Liu, Bowen Liu, Chang‐Qi Ma et al. · Science China Chemistry · 2021 · 604 citations

Natural Sciences, Materials Engineering, Materials Science +14

Recent progress in organic solar cells (Part II device engineering)

Yahui Liu, Bowen Liu, Chang‐Qi Ma et al. · Science China Chemistry · 2022 · 312 citations

Natural Sciences, Materials Engineering, Materials Science +16

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Inkjet printed silver nanowire network as top electrode for semi-transparent organic photovoltaic devices

Hui Lü, Jian Lin, Na Wu et al. · Applied Physics Letters · 2015 · 137 citations

Natural Sciences, Materials Engineering, Materials Science +17